StockNews.AI
EMBC
StockNews.AI
52 days

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

1. Embecta Corp. will discuss Q4 and full year 2024 results on Nov 26. 2. The webcast will also include preliminary FY 2025 financial guidance. 3. Embecta focuses on innovative solutions for diabetes care. 4. The company has a century-long legacy in insulin delivery.

3 mins saved
Full Article

FAQ

Why Bullish?

Forthcoming financial guidance may attract investor interest, similar to past earnings calls boosting stock prices.

How important is it?

Financial results and guidance are critical indicators for EMBC's performance and stock movement.

Why Short Term?

Immediate results from the call will influence market sentiment, reflecting past trends.

Related Companies

INSADIMCK
November 12, 2024 17:31 ET | Source: Embecta Corp. PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal fourth quarter and full year 2024 financial results, and provide an operational update, including preliminary fiscal year 2025 financial guidance, at 8:00 a.m. Eastern Time (ET) on Tuesday, November 26, 2024. Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com. A webcast replay of the call will be available beginning at 11:00 a.m. ET on Nov 26, 2024, via the embecta investor relations website and archived on the website for one year. About embecta embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of more than 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram. Contacts:   Media     Investors  Christian Glazar Pravesh KhandelwalSr. Director, Corporate Communications      VP, Head of Investor Relations908-821-6922   551-264-6547 Contact Media RelationsContact IR

Related News